Variability in the precore and core promoter regions of HBV strains in morocco: Characterization and impact on liver disease progression

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kitab, Bouchra ^a,d   Essaid El Feydi, Abdellah ^b   Afifi, Rajaa ^b   Trepo, Christian ^c   Benazzouz, Mustapha ^b   Essamri, Wafaa ^b   Zoulim, Fabien ^c   Chemin, Isabelle ^c   Alj, Hanane Salih ^d   Ezzikouri, Sayeh ^a   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGE; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOROCCO; MUTATIONAL ANALYSIS; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SEX DIFFERENCE; STOP CODON; VIRUS LOAD; VIRUS STRAIN; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; MOROCCO; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 84865058919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042891     Document Type: Article

References (53)

1. World Health Organization ((2009)) Hepatitis B vaccines. Weekly Epidemiological Record 40:: 405--420.
2. Lavanchy D, ((2004)) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:: 97--107.
3. Sbai A, Baha W, Ougabrai H, Allalia T, Dersi N, et al. (2011) Hepatitis B prevalence and risk factors in Morocco. Pathol Biol (Paris).
4. Ezzikouri S, Chemin I, Chafik A, Wakrim L, Nourlil J, et al. ((2008)) Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 8:: 306--312.
5. Mrani S, Sakhsokh Y, Gille Y, Baaj A, ((2002)) Epidémiologie de l′infection par les hépatites virales B et C. Cah Med. 4:: 87--88.
6. Sebti MF (1984) Acute viral hepatitis and hepatitis B virus markers in chronic liver disease and primary cancer of the liver. IARC Sci Publ: 227-236.
7. Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, El Kihal L, et al. ((2007)) The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol Res 37:: 748--754.
8. Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, et al. ((2011)) Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 63:: 66--75.
9. Baha W, Ennaji MM, Lazar F, Melloul M, El Fahime E, et al. ((2012)) HBV genotypes prevalence, precore and basal core mutants in Morocco. Infect Genet Evol 12:: 1157--1162.
10. Ganem D, Prince AM, ((2004)) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:: 1118--1129.
11. Hadziyannis SJ, ((2011)) Natural history of chronic hepatitis B in Euro- Mediterranean and African countries. J Hepatol 55:: 183--191.
12. Funk ML, Rosenberg DM, Lok AS (2002) World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 9: 52-61.
13. Kramvis A, Kew MC, ((1998)) Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepat 5:: 357--367.
14. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, et al. ((1989)) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2:: 588--591.
15. Kramvis A, Kew MC, ((1999)) The core promoter of hepatitis B virus. J Viral Hepat 6:: 415--427.
16. Kramvis A, Kew MC, ((2005)) Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 12:: 456--464.
17. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG, ((2007)) Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int 27:: 1356--1363.
18. Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, et al. ((2006)) Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 44:: 326--334.
19. Ducancelle A, Servant-Delmas A, Beuvelet T, Balan V, Pivert A, et al. ((2011)) Results of a novel real-time PCR, sequence analysis, Inno-LiPA line probe assays in the detection of hepatitis B virus G1896A precore mutation in French blood donors. Pathol Biol (Paris) 59:: 21--27.
20. Gandhe SS, Chadha MS, Walimbe AM, Arankalle VA, ((2003)) Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat 10:: 367--382.
21. Liu S, Zhang H, Gu C, Yin J, He Y, et al. ((2009)) Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101:: 1066--1082.
22. Kao JH, Chen PJ, Lai MY, Chen DS, ((2003)) Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:: 327--334.
23. Bozdayi AM, Bozkaya H, Turkyilmaz A, Aslan N, Verdi H, et al. ((1999)) Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey. Infection 27:: 357--360.
24. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, et al. ((2008)) Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 198:: 1634--1642.
25. Kurosaki M, Enomoto N, Asahina Y, Sakuma I, Ikeda T, et al. ((1996)) Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B. J Med Virol. 49:: 115--123.
26. Bai X, Zhu Y, Jin Y, Guo X, Qian G, et al. ((2011)) Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. Carcinogenesis 32:: 63--68.
27. Guo X, Jin Y, Qian G, Tu H, ((2008)) Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 49:: 718--725.
28. Benjelloun S, Tong S, Li J, Menfalout L, Trepo C, et al. ((1993)) Pre-core mutation associated with lack of hepatitis B e antigenaemia in Moroccan asymptomatic carriers of the virus. Res Virol 144:: 159--167.
29. Lusida MI, Nugrahaputra VE, Soetjipto, Handajani R, Nagano-Fujii M, et al. ((2008)) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:: 2160--2166.
30. Larzul D, Chevrier D, Thiers V, Guesdon JL, ((1990)) An automatic modified polymerase chain reaction procedure for hepatitis B virus DNA detection. J Virol Methods 27:: 49--60.
31. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. ((2007)) Clustal W and Clustal X version 2.0. Bioinformatics 23:: 2947--2948.
32. Hall TA, ((1999)) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp 41:: 95--98.
33. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J, ((2002)) Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123:: 1848--1856.
34. Jardi R, Rodriguez F, Buti M, Costa X, Valdes A, et al. ((2004)) Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J Hepatol 40:: 507--514.
35. Khelifa F, Thibault V, ((2009)) Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria. Pathol Biol (Paris) 57:: 107--113.
36. Bahri O, Cheikh I, Hajji N, Djebbi A, Maamouri N, et al. ((2006)) Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 78:: 353--357.
37. Bozdayi AM, Bozkaya H, Turkyilmaz AR, Sarýodlu M, Cetinkaya H, et al. ((2001)) Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J Clin Virol 21:: 91--101.
38. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, et al. ((2004)) A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology. 40:: 747--755.
39. Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M, ((2008)) Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 23:: 474--481.
40. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. ((2008)) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100:: 1134--1143.
41. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, et al. ((2007)) Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133:: 1466--1474.
42. Lindh M, Horal P, Dhillon AP, Furuta Y, Norkrans G, ((1996)) Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 24:: 494--501.
43. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P, ((2008)) Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 89:: 901--909.
44. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, et al. ((2003)) Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol 38:: 98--103.
45. Liu CJ, Jeng YM, Chen CL, Cheng HR, Chen PJ, et al. ((2009)) Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B. J Infect Dis. 199:: 742--749.
46. Kim TH, Cho EY, Oh HJ, Choi CS, Kim JW, et al. ((2006)) The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection. J Korean Med Sci 21:: 279--283.
47. Tang H, Oishi N, Kaneko S, Murakami S, ((2006)) Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 97:: 977--983.
48. Wang Y, Lau SH, Sham JS, Wu MC, Wang T, et al. ((2004)) Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene 23:: 142--148.
49. Yotsuyanagi H, Hino K, Tomita E, Toyoda J, Yasuda K, et al. ((2002)) Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol. 37:: 355--363.
50. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, et al. ((2003)) Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77:: 6601--6612.
51. Chan HL, Hussain M, Lok AS, ((1999)) Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 29:: 976--984.
52. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, et al. ((2006)) Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45:: 646--653.
53. Baumert TF, Rogers SA, Hasegawa K, Liang TJ, ((1996)) Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98:: 2268--2276.